EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan

Tsubasa Nishinosono, Hideki Muramatsu, Manabu Wakamatsu, Motoshi Sonoda, Katsuhide Eguchi, Koji Kawaguchi, Takeshi Yamamoto, Takahiro Kudo, Michiko Kajiwara, Masataka Ishimura, Yoshiyuki Takahashi

Journal of Clinical Immunology · 28.03.2026 · 46 (1)

DOI: 10.1007/s10875-026-02008-y ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Clinical Immunology, online erschienen am 28.03.2026. Verfasst von Tsubasa Nishinosono und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nagoya University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Congenital athymia is a life-threatening condition characterized by thymic absence and profound T-cell immunodeficiency. Thymus implantation is the definitive treatment, but its availability is limited. This study aimed to evaluate the outcomes of hematopoietic cell transplantation (HCT) as an alternative therapy.

Methods

A nationwide, multicenter, retrospective study analyzed nine patients who underwent allogeneic HCT between 2000 and 2024 in Japan. Overall survival (OS) was estimated using the Kaplan–Meier method, and the cumulative incidence of immunodeficiency-related mortality was assessed using Gray’s test.

Results

Among the nine patients, eight (89%) received umbilical cord blood, and one (11%) received related peripheral blood. Seven patients (78%) underwent transplantation without conditioning. Engraftment with T-cell recovery was achieved in six patients (67%), with a median CD4 + T-cell count of 0.352 × 10 9 /L (range, 0.216–1.578 × 10 9 /L) at the last follow-up. Acute graft-versus-host disease (GVHD) occurred in five patients (56%), all with Grade I–II skin involvement. No chronic GVHD was observed. The one-year OS rate was 66.7% (95% confidence interval: 28.2%–87.8%). Overall, six patients (67%) died: three early deaths within the first month from infections, and three late deaths beyond 1 year from congenital comorbidities. HCT before six months of age was associated with significantly lower immunodeficiency-related mortality ( p = 0.02).

Conclusion

HCT can allow immune reconstitution in congenital athymia, although long-term survival is affected by comorbidities. Early diagnosis and timely intervention are crucial in managing this condition. HCT can be a restricted alternative therapy for patients ineligible for thymus implantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationFemaleHumansInfantMaleGraft vs Host DiseaseJapanRetrospective StudiesTransplantation ConditioningTransplantation, HomologousTreatment OutcomeInfant, Newborn

Stichwörter der Autor:innen

22q11.2 deletion syndromeCHARGE syndromeComplete DiGeorge syndromeCongenital athymiaHematopoietic cell transplantation

Autor:innen und Institutionen

  • Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan.
  • Department of Pediatric Critical Care, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Department of Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8560, Japan. hideki-muramatsu@med.nagoya-u.ac.jp.
  • Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Hematology and Oncology, Shizuoka Children's Hospital, Shizuoka, Japan.
  • Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.

Förderung

  • Nagoya University

Zitieren

APA

Nishinosono, T., Muramatsu, H., Wakamatsu, M., Sonoda, M., Eguchi, K., Kawaguchi, K., Yamamoto, T., Kudo, T., Kajiwara, M., Ishimura, M., & Takahashi, Y. (2026). Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan. Journal of Clinical Immunology, 46(1). https://doi.org/10.1007/s10875-026-02008-y

Vancouver

Nishinosono T, Muramatsu H, Wakamatsu M, Sonoda M, Eguchi K, Kawaguchi K, et al. Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan. Journal of Clinical Immunology. 2026;46(1). doi:10.1007/s10875-026-02008-y

BibTeX
@article{Nishinosono2026,
  author = {Nishinosono, Tsubasa and Muramatsu, Hideki and Wakamatsu, Manabu and Sonoda, Motoshi and Eguchi, Katsuhide and Kawaguchi, Koji and Yamamoto, Takeshi and Kudo, Takahiro and Kajiwara, Michiko and Ishimura, Masataka and Takahashi, Yoshiyuki},
  title = {Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan},
  journal = {Journal of Clinical Immunology},
  year = {2026},
  volume = {46},
  number = {1},
  doi = {10.1007/s10875-026-02008-y}
}
Kostenlos starten →